Home Commutability assessment of reference materials for homocysteine
Article
Licensed
Unlicensed Requires Authentication

Commutability assessment of reference materials for homocysteine

  • Tongtong Xing , Jianyi Liu , Haofeng Sun , Yanhong Gao EMAIL logo , Yi Ju , Xiaolin Liu EMAIL logo and Dewei Song EMAIL logo
Published/Copyright: August 18, 2022

Abstract

Objectives

Commutability of reference materials is essential for ensuring the traceability of patient measurement results and the technical basis for the use of reference materials. Commutability is only relevant for matrixed reference material; it is a prerequisite for the accuracy and authenticity of calibration methods. In this study, we evaluated the commutability of reference materials for homocysteine.

Methods

Five conventional measurement methods were applied to simultaneously measure 30 serum samples and seven homocysteine reference materials from the National Institute of Standards and Technology and the National Institute of Metrology. Liquid chromatography tandem-mass spectrometry was used as a reference method. Two methods were used to evaluate the commutability of the seven reference materials according to the Clinical and Laboratory Standards Institute EP30-A and the International Federation of Clinical Chemistry and Laboratory Medicine (IFCC) commutability assessment document.

Results

Among 35 combinations of the five conventional methods and seven reference materials, after evaluation in accordance with the EP30-A, the seven reference materials passed the commutability assessment, and 34 combinations were commutable. According to the IFCC, the commutability evaluation of 28 combinations was conclusive (commutable or non-commutable), while results for the remaining seven combinations could not be determined.

Conclusions

The homocysteine reference materials showed good commutability. The sensitivity of the measurement procedure, measurement deviation and uncertainty, and differences in the “measurand” selected by different methods may affect the evaluation results. Additionally, different judgment standards for different methods may explain the observed variations in evaluation results.


Corresponding authors: Dewei Song, Division of Chemical Metrology and Analytical Science, National Institute of Metrology (Key Laboratory of Chemical Metrology and Applications on Nutrition and Health for State Market Regulation), Beijing 100029, P.R. China, Phone: +86 10 64524789, E-mail: ; Yanhong Gao, Laboratory Department of the First Medical Center of PLA General Hospital, Beijing 100039, P.R. China, E-mail: ; and Xiaolin Liu, School of Chemical Engineering, Beijing University of Chemical Technology, Beijing 100029, P.R. China, E-mail:

Award Identifier / Grant number: 2017YFF0205401

Funding source: National Institute of Metrology Fundamental Research Project

Award Identifier / Grant number: AKYZD2115-1

  1. Research funding: This work was financially supported by the National Key Research and Development Program of China (grant no. 2017YFF0205401) and by the National Institute of Metrology Fundamental Research Project (grant no. AKYZD2115-1).

  2. Author contributions: All authors have accepted responsibility for the entire content of this manuscript and approved its submission.

  3. Competing interests: Authors state no conflict of interest.

  4. Informed consent: Not applicable.

  5. Ethical approval: Not applicable.

References

1. Vesper, HW, Miller, WG, Myers, GL. Reference materials and commutability. Clin Biochem Rev 2007;28:139–47.Search in Google Scholar

2. Miller, WG, Myers, GL, Rej, R. Why commutability matters. Clin Chem 2006;52:553–4, https://doi.org/10.1373/clinchem.2005.063511.Search in Google Scholar PubMed

3. Miller, WG, Myers, GL. Commutability still matters. Clin Chem 2013;59:1291–3, https://doi.org/10.1373/clinchem.2013.208785.Search in Google Scholar PubMed

4. Braga, F, Panteghini, M. Commutability of reference and control materials: an essential factor for assuring the quality of measurements in laboratory medicine. Clin Chem Lab Med 2019;57:967–73, https://doi.org/10.1515/cclm-2019-0154.Search in Google Scholar PubMed

5. Clinical and Laboratory Standards Institute (CLSI). Characterization and qualification of commutable reference materials for laboratory medicine; Approved Guideline. CLSI document EP30-A. Wayne, PA: Clinical and Laboratory Standards Institute; 2010.Search in Google Scholar

6. Clinical and Laboratory Standards Institute (CLSI). Evaluation of commutability of processed samples; Approved Guideline-Third Edition. CLSI document EP14-A3. Wayne, PA: Clinical and Laboratory Standards Institute; 2014.Search in Google Scholar

7. Miller, WG, Schimmel, H, Rej, R, Greenberg, N, Ceriotti, F, Burns, C, et al.. IFCC working group recommendations for assessing commutability part 1: general experimental design. Clin Chem 2018;64:447–54, https://doi.org/10.1373/clinchem.2017.277525.Search in Google Scholar PubMed PubMed Central

8. Nilsson, G, Budd, JR, Greenberg, N, Delatour, V, Rej, R, Panteghini, M, et al.. IFCC working group recommendations for assessing commutability part 2: using the difference in bias between a reference material and clinical samples. Clin Chem 2018;64:455–64, https://doi.org/10.1373/clinchem.2017.277541.Search in Google Scholar PubMed PubMed Central

9. Budd, JR, Weykamp, C, Rej, R, MacKenzie, F, Ceriotti, F, Greenberg, N, et al.. IFCC working group recommendations for assessing commutability part 3: using the calibration effectiveness of a reference material. Clin Chem 2018;64:465–74, https://doi.org/10.1373/clinchem.2017.277558.Search in Google Scholar PubMed

10. Delatour, V, Liu, Q, Vesper, HW, Commutability L-LWGo. Commutability assessment of external quality assessment materials with the difference in bias approach: are acceptance criteria based on medical requirements too strict? Clin Chem 2016;62:1670–1, https://doi.org/10.1373/clinchem.2016.261008.Search in Google Scholar PubMed PubMed Central

11. Carobene, A. Reliability of biological variation data available in an online database: need for improvement. Clin Chem Lab Med 2015;53:871–7, https://doi.org/10.1515/cclm-2014-1133.Search in Google Scholar PubMed

12. Deprez, L, Toussaint, B, Zegers, I, Schimmel, H, Grote-Koska, D, Klauke, R, et al.. Commutability assessment of candidate reference materials for pancreatic alpha-amylase. Clin Chem 2018;64:1193–202, https://doi.org/10.1373/clinchem.2018.289744.Search in Google Scholar PubMed

13. Chrysant, SG, Chrysant, GS. The current status of homocysteine as a risk factor for cardiovascular disease: a mini review. Expert Rev Cardiovasc Ther 2018;16:559–65, https://doi.org/10.1080/14779072.2018.1497974.Search in Google Scholar PubMed

14. Li, S, Sun, L, Qi, L, Jia, Y, Cui, Z, Wang, Z, et al.. Effect of high homocysteine level on the severity of coronary heart disease and prognosis after stent implantation. J Cardiovasc Pharmacol 2020;76:101–5, https://doi.org/10.1097/fjc.0000000000000829.Search in Google Scholar PubMed

15. Zhao, M, Wang, X, He, M, Qin, X, Tang, G, Huo, Y, et al.. Homocysteine and stroke risk: modifying effect of methylenetetrahydrofolate reductase C677T polymorphism and folic acid intervention. Stroke 2017;48:1183–90, https://doi.org/10.1161/strokeaha.116.015324.Search in Google Scholar PubMed

16. Feng, Y, Kang, K, Xue, Q, Chen, Y, Wang, W, Cao, J. Value of plasma homocysteine to predict stroke, cardiovascular diseases, and new-onset hypertension: a retrospective cohort study. Medicine (Baltim) 2020;99:e21541, https://doi.org/10.1097/md.0000000000021541.Search in Google Scholar PubMed PubMed Central

17. Windelberg, A, Arseth, O, Kvalheim, G, Ueland, PM. Automated assay for the determination of methylmalonic acid, total homocysteine, and related amino acids in human serum or plasma by means of methylchloroformate derivatization and gas chromatography-mass spectrometry. Clin Chem 2005;51:2103–9, https://doi.org/10.1373/clinchem.2005.053835.Search in Google Scholar PubMed

18. Nelson, BC, Pfeiffer, CM, Sniegoski, LT, Satterfield, MB. Development and evaluation of an isotope dilution LC/MS method for the determination of total homocysteine in human plasma. Anal Chem 2003;75:775–84, https://doi.org/10.1021/ac0204799.Search in Google Scholar PubMed

19. Hellmuth, C, Koletzko, B, Peissner, W. Aqueous normal phase chromatography improves quantification and qualification of homocysteine, cysteine and methionine by liquid chromatography-tandem mass spectrometry. J Chromatogr, B: Anal Technol Biomed Life Sci 2011;879:83–9, https://doi.org/10.1016/j.jchromb.2010.11.016.Search in Google Scholar PubMed

20. Jiang, Y, Mistretta, B, Elsea, S, Sun, Q. Simultaneous determination of plasma total homocysteine and methionine by liquid chromatography-tandem mass spectrometry. Clin Chim Acta 2017;464:93–7, https://doi.org/10.1016/j.cca.2016.11.017.Search in Google Scholar PubMed

21. Satterfield, MB, Sniegoski, LT, Welch, MJ, Nelson, BC, Pfeiffer, CM. Comparison of isotope dilution mass spectrometry methods for the determination of total homocysteine in plasma and serum. Anal Chem 2003;75:4631–8, https://doi.org/10.1021/ac034207x.Search in Google Scholar PubMed

22. Liu, Y, Song, D, Xu, B, Li, H, Dai, X, Chen, B. Development of a matrix-based candidate reference material of total homocysteine in human serum. Anal Bioanal Chem 2017;409:3329–35, https://doi.org/10.1007/s00216-017-0272-3.Search in Google Scholar PubMed

23. Tomaiuolo, M, Vecchione, G, Margaglione, M, Pisanelli, D, Grandone, E. Stable-isotope dilution LC-ESI-MS/MS techniques for the quantification of total homocysteine in human plasma. J Chromatogr, B: Anal Technol Biomed Life Sci 2009;877:3292–9, https://doi.org/10.1016/j.jchromb.2009.07.024.Search in Google Scholar PubMed

24. Satterfield, MB, Sniegoski, LT, Sharpless, KE, Welch, MJ, Hornikova, A, Zhang, NF, et al.. Development of a new standard reference material: SRM 1955 (homocysteine and folate in human serum). Anal Bioanal Chem 2006;385:612–22, https://doi.org/10.1007/s00216-006-0434-1.Search in Google Scholar PubMed

25. Rossi, E, Beilby, JP, McQuillan, BM, Hung, J. Biological variabiity and reference intervals for total plasma homocysteine. Ann Clin Biochem 1999;36:56–61. https://doi.org/10.1177/000456329903600107.Search in Google Scholar PubMed


Supplementary Material

The online version of this article offers supplementary material (https://doi.org/10.1515/cclm-2022-0388).


Received: 2022-04-21
Accepted: 2022-07-18
Published Online: 2022-08-18
Published in Print: 2022-09-27

© 2022 Walter de Gruyter GmbH, Berlin/Boston

Articles in the same Issue

  1. Frontmatter
  2. Editorial
  3. The relevance of establishing method-dependent decision thresholds of serum folate in pregnancy and lactation: when the laboratory stewardship meets the health-care needs
  4. Reviews
  5. Strategies to minimise the current disadvantages experienced by women in faecal immunochemical test-based colorectal cancer screening
  6. What is the impact of circulating histones in COVID-19: a systematic review
  7. Mini Review
  8. Diagnostic utility of pleural cell-free nucleic acids in undiagnosed pleural effusions
  9. Guidelines and Recommendations
  10. Evaluation of the cardiovascular risk in patients undergoing major non-cardiac surgery: role of cardiac-specific biomarkers
  11. Genetics and Molecular Diagnostics
  12. Detection of DNA copy number alterations by matrix-assisted laser desorption/ionization time-of-flight mass spectrometric analysis of single nucleotide polymorphisms
  13. General Clinical Chemistry and Laboratory Medicine
  14. Fifty years of newborn screening for congenital hypothyroidism: current status in Australasia and the case for harmonisation
  15. Commutability assessment of reference materials for homocysteine
  16. External quality assessment for detection of methylated Syndecan 2 (SDC2) in China
  17. Patient-based real-time quality control for quantitative hepatitis B virus DNA test using moving rate of positive and negative patient results
  18. Performance of HDL-C measurements assessed by a 4-year trueness-based EQA/PT program in China
  19. Two-site evaluation of the Roche Elecsys Vitamin D total III assay
  20. A novel point-of-care device accurately measures thyrotropin in whole blood, capillary blood and serum
  21. IgA rheumatoid factor in rheumatoid arthritis
  22. Reference Values and Biological Variations
  23. Reference intervals of 14 biochemical markers for children and adolescence in China: the PRINCE study
  24. Chinese normotensive and essential hypertensive reference intervals for plasma aldosterone and renin activity by liquid chromatography-tandem mass spectrometry
  25. Biological variation estimates obtained from Chinese subjects for 32 biochemical measurands in serum
  26. Cancer Diagnostics
  27. Testosterone analysis in castrated prostate cancer patients: suitability of the castration cut-off and analytical accuracy of the present-day clinical immunoassays
  28. Cardiovascular Diseases
  29. Point-of-care high-sensitivity troponin-I analysis in capillary blood for acute coronary syndrome diagnostics
  30. Platelet count and clinical outcomes among ischemic stroke patients with endovascular thrombectomy in DIRECT-MT
  31. Infectious Diseases
  32. Measurement of anti SARS-CoV-2 RBD IgG in saliva: validation of a highly sensitive assay and effects of the sampling collection method and correction by protein
  33. Letters to the Editors
  34. The simple reproducibility of a measurement result does not equal its overall measurement uncertainty
  35. Complexity of serological assays and misunderstandings of WHO International Units
  36. Ct values of different SARS CoV2 variants: a single center observational study from Innsbruck, Austria
  37. Alignment of the new generation of Abbott Alinity γ-glutamyltransferase assay to the IFCC reference measurement system should be improved
  38. Thermal and chronological stability of monocyte distribution width (MDW), the new biomarker for sepsis
  39. Two comments for the current commutability assessment
  40. Plasma neurofilament light chain in Chinese children with later-onset spinal muscular atrophy
Downloaded on 23.9.2025 from https://www.degruyterbrill.com/document/doi/10.1515/cclm-2022-0388/html
Scroll to top button